• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童 COVID-19 相关多系统炎症综合征(MIS-C)。

COVID-19-Related Multi-systemic Inflammatory Syndrome in Children (MIS-C).

机构信息

Division of Immunology, Boston Children's Hospital, Boston, MA, USA.

Harvard Medical School, Boston, MA, USA.

出版信息

Adv Exp Med Biol. 2024;1448:409-425. doi: 10.1007/978-3-031-59815-9_28.

DOI:10.1007/978-3-031-59815-9_28
PMID:39117830
Abstract

Multisystem inflammatory syndrome in children (MIS-C) is a severe complication of SARS-CoV-2 infections in children. This syndrome manifests about a month after the initial viral infection and is characterized by fever, multiorgan dysfunction, and systemic inflammation. This chapter will review the emergence, epidemiology, clinical characteristics, diagnosis, pathophysiology, immunomodulatory treatment, prognosis, outcomes, and prevention of MIS-C. While the pathophysiology of MIS-C remains to be defined, it is a post-infection, hyperinflammatory syndrome of childhood with elevated inflammatory cytokines.

摘要

儿童多系统炎症综合征(MIS-C)是儿童 SARS-CoV-2 感染的严重并发症。该综合征在初始病毒感染后约一个月出现,表现为发热、多器官功能障碍和全身炎症。本章将回顾 MIS-C 的出现、流行病学、临床特征、诊断、病理生理学、免疫调节治疗、预后、结局和预防。虽然 MIS-C 的病理生理学仍有待确定,但它是一种儿童感染后、炎症细胞因子升高的超炎症综合征。

相似文献

1
COVID-19-Related Multi-systemic Inflammatory Syndrome in Children (MIS-C).儿童 COVID-19 相关多系统炎症综合征(MIS-C)。
Adv Exp Med Biol. 2024;1448:409-425. doi: 10.1007/978-3-031-59815-9_28.
2
Phenotype, Susceptibility, Autoimmunity, and Immunotherapy Between Kawasaki Disease and Coronavirus Disease-19 Associated Multisystem Inflammatory Syndrome in Children.川崎病与儿童新型冠状病毒病相关的多系统炎症综合征之间的表型、易感性、自身免疫和免疫治疗。
Front Immunol. 2021 Feb 26;12:632890. doi: 10.3389/fimmu.2021.632890. eCollection 2021.
3
Multisystem Inflammatory Syndrome in Children (MIS-C).儿童多系统炎症综合征(MIS-C)。
Curr Allergy Asthma Rep. 2022 May;22(5):53-60. doi: 10.1007/s11882-022-01031-4. Epub 2022 Mar 22.
4
[Multisystem inflammatory syndrome in children in the context of coronavirus disease 2019 pandemic].[2019冠状病毒病大流行背景下的儿童多系统炎症综合征]
Zhongguo Dang Dai Er Ke Za Zhi. 2024 Jan 15;26(1):98-102. doi: 10.7499/j.issn.1008-8830.2306093.
5
Multisystem Inflammatory Syndrome in Children (MIS-C) Following SARS-CoV-2 Infection: Role of Oxidative Stress.新型冠状病毒2感染后儿童多系统炎症综合征(MIS-C):氧化应激的作用
Front Immunol. 2021 Oct 19;12:723654. doi: 10.3389/fimmu.2021.723654. eCollection 2021.
6
Multisystem Inflammatory Syndrome in Children and Long COVID: The SARS-CoV-2 Viral Superantigen Hypothesis.儿童多系统炎症综合征与长新冠:SARS-CoV-2 病毒超抗原假说。
Front Immunol. 2022 Jul 7;13:941009. doi: 10.3389/fimmu.2022.941009. eCollection 2022.
7
Upregulation of type 1 conventional dendritic cells implicates antigen cross-presentation in multisystem inflammatory syndrome.1 型传统树突状细胞的上调提示抗原交叉呈递在多系统炎症综合征中的作用。
J Allergy Clin Immunol. 2022 Mar;149(3):912-922. doi: 10.1016/j.jaci.2021.10.015. Epub 2021 Oct 22.
8
Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).儿童多系统炎症综合征(MIS-C)中 SARS-CoV-2 血清学的定量分析。
Pediatrics. 2020 Dec;146(6). doi: 10.1542/peds.2020-018242. Epub 2020 Sep 2.
9
Polyclonal expansion of TCR Vbeta 21.3 CD4 and CD8 T cells is a hallmark of Multisystem Inflammatory Syndrome in Children.TCR Vβ21.3+ CD4 和 CD8 T 细胞的多克隆扩增是儿童多系统炎症综合征的一个标志。
Sci Immunol. 2021 May 25;6(59). doi: 10.1126/sciimmunol.abh1516.
10
Similarities and differences between the immunopathogenesis of COVID-19-related pediatric multisystem inflammatory syndrome and Kawasaki disease.COVID-19 相关儿童多系统炎症综合征与川崎病的免疫发病机制异同。
J Clin Invest. 2021 Mar 15;131(6). doi: 10.1172/JCI144554.

本文引用的文献

1
Anakinra treatment in multisystemic inflammatory syndrome in children (MIS-C) associated with COVID-19.阿那白滞素治疗与新型冠状病毒肺炎相关的儿童多系统炎症综合征(MIS-C)。
Front Pediatr. 2022 Aug 18;10:942455. doi: 10.3389/fped.2022.942455. eCollection 2022.
2
SARS-CoV-2-specific T cell responses in patients with multisystem inflammatory syndrome in children.儿童多系统炎症综合征患者中的 SARS-CoV-2 特异性 T 细胞应答。
Clin Immunol. 2022 Oct;243:109106. doi: 10.1016/j.clim.2022.109106. Epub 2022 Aug 30.
3
Biologic disease-modifying antirheumatic drugs to treat multisystem inflammatory syndrome in children.
生物制剂类改善病情抗风湿药治疗儿童多系统炎症综合征。
Curr Opin Rheumatol. 2022 Sep 1;34(5):274-279. doi: 10.1097/BOR.0000000000000889. Epub 2022 Jul 5.
4
The clinical features and estimated incidence of MIS-C in Cape Town, South Africa.南非开普敦儿童多系统炎症综合征的临床特征和估计发病率。
BMC Pediatr. 2022 May 2;22(1):241. doi: 10.1186/s12887-022-03308-z.
5
Autoantibodies against interleukin-1 receptor antagonist in multisystem inflammatory syndrome in children: a multicentre, retrospective, cohort study.儿童多系统炎症综合征中抗白细胞介素-1受体拮抗剂自身抗体的研究:一项多中心、回顾性队列研究
Lancet Rheumatol. 2022 May;4(5):e329-e337. doi: 10.1016/S2665-9913(22)00064-9. Epub 2022 Mar 29.
6
Autoantibodies Against Proteins Previously Associated With Autoimmunity in Adult and Pediatric Patients With COVID-19 and Children With MIS-C.COVID-19 成年和儿科患者以及 MIS-C 患儿中与自身免疫相关的蛋白的自身抗体。
Front Immunol. 2022 Mar 11;13:841126. doi: 10.3389/fimmu.2022.841126. eCollection 2022.
7
Who Would Have Predicted Multisystem Inflammatory Syndrome in Children?谁能预测儿童多系统炎症综合征?
Curr Rheumatol Rep. 2022 Jan;24(1):1-11. doi: 10.1007/s11926-022-01056-8. Epub 2022 Feb 12.
8
American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 3.美国风湿病学会儿童 COVID-19 相关 SARS-CoV-2 与儿童多系统炎症综合征及过度炎症的临床指导:第 3 版
Arthritis Rheumatol. 2022 Apr;74(4):e1-e20. doi: 10.1002/art.42062. Epub 2022 Feb 3.
9
Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12-18 Years - United States, July-December 2021.辉瑞-生物科技的 BNT162b2 (Pfizer-BioNTech) mRNA 疫苗在 12-18 岁人群中预防儿童多系统炎症综合征的有效性-美国,2021 年 7 月至 12 月。
MMWR Morb Mortal Wkly Rep. 2022 Jan 14;71(2):52-58. doi: 10.15585/mmwr.mm7102e1.
10
Multisystem Inflammatory Syndrome in Children by COVID-19 Vaccination Status of Adolescents in France.法国青少年 COVID-19 疫苗接种状况与儿童多系统炎症综合征的关系。
JAMA. 2022 Jan 18;327(3):281-283. doi: 10.1001/jama.2021.23262.